In summary, this study suggests that microglial VPS35 deficiency enhances Aβ pathology and accelerates cognitive decline in 5XFAD mice, an AD animal model, supporting the view for VPS35 deficiency as a risk factor for AD development. The gene discussed is VPS35; the disease is Alzheimer disease.